Day: June 14, 2023

VANCOUVER, British Columbia, June 14, 2023 (GLOBE NEWSWIRE) — Aldebaran Resources Inc. (“Aldebaran” or the “Company”) (TSX-V: ALDE, OTCQX: ADBRF), is pleased to announce it has completed its previously announced top-up financing with a subsidiary of South32 Limited (“South32”). South32 elected to exercise its anti-dilution rights to maintain a 9.9% equity interest in the Company following the exercise of warrants announced on May 5, 2023. South32 acquired 970,000 common shares (the “Common Shares”) at a price of $0.73 per Common Share for total proceeds of $708,100. In accordance with the terms of the Investor Rights Agreement between the Company and South32, the issue price was set at the volume weighted average price of the Common Shares in the five day period preceding the election notice by South32. The Common Shares issued...

Balance Sheet Initiatives Bolster Financial Strength as Company Scales Business Towards Cash Flow Break-Even SAN FRANCISCO, June 14, 2023 (GLOBE NEWSWIRE) — Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation, today announced that it has amended its existing senior secured term loan facility with Silicon Valley Bank (“SVB”), a division of First Citizens Bank, which may extend the interest only period by as long as 18 months from January 2024 to July 2025, and finalized terms on its previously disclosed equity line of credit with Redmile Group, LLC (“Redmile”). Combined with the $12 million of new equity from HCA Healthcare, Inc. and Redmile announced in April 2023, these actions bolster the Company’s financial strength and enhance its liquidity cushion as it scales...

Reykjavík Energy (Orkuveita Reykjavíkur; OR) is holding a bond auction Tuesday, June 20, 2023. Bond in the green bond classes OR020934 GB and OR180255 GB will be offered for sale. OR020934 GB bears fixed indexed interests and pays equal payments every six months with a final maturity date of September 2, 2034. Previously, bonds with a nominal value of ISK 17,747 million have been issued in the class.  OR0180255 GB bears fixed indexed interest and pays equal payments every six months with a final maturity date of February 18, 2055. Previously, bonds with a nominal value of ISK 25,201 million have been issued in the class.  Fossar Investment Bank hf. oversees the issuance and sale of the bonds as well as their admission to trading on the Nasdaq sustainable bonds market in Iceland. Bids must be submitted to the email address utbod@fossar.is...

Golar LNG Limited advises that its 2023 Annual General Meeting will be held on August 8, 2023.  The record date for voting at the Annual General Meeting is set to June 15, 2023. The notice, agenda and associated material will be distributed prior to the meeting. Golar LNG LimitedHamilton, BermudaJune 14, 2023 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Bids, sales, stop-rates and prices are presented in the table below:      ISIN Bid Mill. kr. (nominal) Sale Stop-rate (per cent) Pro-rata Price98 19070 DKT 01/09/23 III 3,200 2,200 3,070 100 % 99.347698 19153 DKT 01/12/23 IV 1,680 1,580 3.170 100 % 98.5422Total 4,880 3,780      The sale will settle 16 June 2023.

Philips Neuro suiteJune 14, 2023 Economic analysis of cost of Vall d’Hebron University Hospital Stroke Unit shows direct-to-angio stroke pathway can save more than USD 3,000 per patient Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of a health economic analysis published in the Journal of NeuroInterventional Surgery (JNIS) that show an innovative approach to the stroke care pathway reduced costs by an average of EUR 2,848 (~USD 3,120) per patient. The retrospective analysis looked at data from the controlled single-center ANGIOCAT clinical trial conducted at the Vall d’Hebron University Hospital Stroke Unit (Barcelona, Spain) [1]. Earlier results from this study demonstrated that a ‘Direct-to-Angio Suite’ (DTAS) pathway improves clinical outcomes...